Literature DB >> 28143649

Crosstalk between calcium and reactive oxygen species signaling in cancer.

Nadine Hempel1, Mohamed Trebak2.   

Abstract

The interplay between Ca2+ and reactive oxygen species (ROS) signaling pathways is well established, with reciprocal regulation occurring at a number of subcellular locations. Many Ca2+ channels at the cell surface and intracellular organelles, including the endoplasmic reticulum and mitochondria are regulated by redox modifications. In turn, Ca2+ signaling can influence the cellular generation of ROS, from sources such as NADPH oxidases and mitochondria. This relationship has been explored in great depth during the process of apoptosis, where surges of Ca2+ and ROS are important mediators of cell death. More recently, coordinated and localized Ca2+ and ROS transients appear to play a major role in a vast variety of pro-survival signaling pathways that may be crucial for both physiological and pathophysiological functions. While much work is required to firmly establish this Ca2+-ROS relationship in cancer, existing evidence from other disease models suggests this crosstalk is likely of significant importance in tumorigenesis. In this review, we describe the regulation of Ca2+ channels and transporters by oxidants and discuss the potential consequences of the ROS-Ca2+ interplay in tumor cells.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcium channels; Calcium signaling; Cancer; Mitochondria; NADPH oxidase; Reactive oxygen species signaling; Tumorigenesis

Mesh:

Substances:

Year:  2017        PMID: 28143649      PMCID: PMC5466514          DOI: 10.1016/j.ceca.2017.01.007

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  351 in total

1.  Accumulation of free ADP-ribose from mitochondria mediates oxidative stress-induced gating of TRPM2 cation channels.

Authors:  Anne-Laure Perraud; Christina L Takanishi; Betty Shen; Shin Kang; Megan K Smith; Carsten Schmitz; Heather M Knowles; Dana Ferraris; Weixing Li; Jie Zhang; Barry L Stoddard; Andrew M Scharenberg
Journal:  J Biol Chem       Date:  2004-11-23       Impact factor: 5.157

2.  Hypoxia leads to Na,K-ATPase downregulation via Ca(2+) release-activated Ca(2+) channels and AMPK activation.

Authors:  Galina A Gusarova; Humberto E Trejo; Laura A Dada; Arturo Briva; Lynn C Welch; Robert B Hamanaka; Gökhan M Mutlu; Navdeep S Chandel; Murali Prakriya; Jacob I Sznajder
Journal:  Mol Cell Biol       Date:  2011-07-05       Impact factor: 4.272

Review 3.  Redox modulation of STIM-ORAI signaling.

Authors:  Rajesh Bhardwaj; Matthias A Hediger; Nicolas Demaurex
Journal:  Cell Calcium       Date:  2016-03-19       Impact factor: 6.817

4.  Orai3 is an estrogen receptor α-regulated Ca²⁺ channel that promotes tumorigenesis.

Authors:  Rajender K Motiani; Xuexin Zhang; Kelly E Harmon; Rebecca S Keller; Khalid Matrougui; James A Bennett; Mohamed Trebak
Journal:  FASEB J       Date:  2012-09-19       Impact factor: 5.191

5.  S-glutathionylation activates STIM1 and alters mitochondrial homeostasis.

Authors:  Brian J Hawkins; Krishna M Irrinki; Karthik Mallilankaraman; Yu-Chin Lien; Youjun Wang; Cunnigaiper D Bhanumathy; Ramasamy Subbiah; Michael F Ritchie; Jonathan Soboloff; Yoshihiro Baba; Tomohiro Kurosaki; Suresh K Joseph; Donald L Gill; Muniswamy Madesh
Journal:  J Cell Biol       Date:  2010-08-02       Impact factor: 10.539

6.  Blockade of NOX2 and STIM1 signaling limits lipopolysaccharide-induced vascular inflammation.

Authors:  Rajesh Kumar Gandhirajan; Shu Meng; Harish C Chandramoorthy; Karthik Mallilankaraman; Salvatore Mancarella; Hui Gao; Roshanak Razmpour; Xiao-Feng Yang; Steven R Houser; Ju Chen; Walter J Koch; Hong Wang; Jonathan Soboloff; Donald L Gill; Muniswamy Madesh
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

7.  Lovastatin inhibits human B lymphoma cell proliferation by reducing intracellular ROS and TRPC6 expression.

Authors:  Xiang Song; Bing-Chen Liu; Xiao-Yu Lu; Li-Li Yang; Yu-Jia Zhai; Amity F Eaton; Tiffany L Thai; Douglas C Eaton; He-Ping Ma; Bao-Zhong Shen
Journal:  Biochim Biophys Acta       Date:  2014-02-08

8.  Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes.

Authors:  D B Zorov; C R Filburn; L O Klotz; J L Zweier; S J Sollott
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

Review 9.  Mitochondrial reactive oxygen species and cancer.

Authors:  Lucas B Sullivan; Navdeep S Chandel
Journal:  Cancer Metab       Date:  2014-11-28

Review 10.  An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins--From superoxide dismutation to H2O2-driven pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Ivan Spasojevic
Journal:  Redox Biol       Date:  2015-02-07       Impact factor: 11.799

View more
  55 in total

Review 1.  Interactions of nanomaterials with ion channels and related mechanisms.

Authors:  Suhan Yin; Jia Liu; Yiyuan Kang; Yuqing Lin; Dongjian Li; Longquan Shao
Journal:  Br J Pharmacol       Date:  2019-09-04       Impact factor: 8.739

2.  Overview on Interactive Role of Inflammation, Reactive Oxygen Species, and Calcium Signaling in Asthma, COPD, and Pulmonary Hypertension.

Authors:  Lillian Truong; Yun-Min Zheng; Sharath Kandhi; Yong-Xiao Wang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Mitochondrial Ca2+ transport in the endothelium: regulation by ions, redox signalling and mechanical forces.

Authors:  B Rita Alevriadou; Santhanam Shanmughapriya; Akshar Patel; Peter B Stathopulos; Muniswamy Madesh
Journal:  J R Soc Interface       Date:  2017-12-13       Impact factor: 4.118

Review 4.  The role of the mitochondrial calcium uniporter (MCU) complex in cancer.

Authors:  Adina Vultur; Christine S Gibhardt; Hedwig Stanisz; Ivan Bogeski
Journal:  Pflugers Arch       Date:  2018-06-21       Impact factor: 3.657

5.  Curcumin and NCLX inhibitors share anti-tumoral mechanisms in microsatellite-instability-driven colorectal cancer.

Authors:  William Raoul; Thierry Lecomte; Maxime Guéguinou; Sajida Ibrahim; Jérôme Bourgeais; Alison Robert; Trayambak Pathak; Xuexin Zhang; David Crottès; Jacques Dupuy; David Ternant; Valérie Monbet; Roseline Guibon; Hector Flores-Romero; Antoine Lefèvre; Stéphanie Lerondel; Alain Le Pape; Jean-François Dumas; Philippe G Frank; Alban Girault; Romain Chautard; Françoise Guéraud; Ana J García-Sáez; Mehdi Ouaissi; Patrick Emond; Olivier Sire; Olivier Hérault; Gaëlle Fromont-Hankard; Christophe Vandier; David Tougeron; Mohamed Trebak
Journal:  Cell Mol Life Sci       Date:  2022-05-08       Impact factor: 9.261

6.  Dichotomous role of the human mitochondrial Na+/Ca2+/Li+ exchanger NCLX in colorectal cancer growth and metastasis.

Authors:  Trayambak Pathak; Maxime Gueguinou; Vonn Walter; Celine Delierneux; Martin T Johnson; Xuexin Zhang; Ping Xin; Ryan E Yoast; Scott M Emrich; Gregory S Yochum; Israel Sekler; Walter A Koltun; Donald L Gill; Nadine Hempel; Mohamed Trebak
Journal:  Elife       Date:  2020-09-11       Impact factor: 8.140

Review 7.  Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1-5 and Superoxide Dismutase 1-3 Signal Transduction Pathways.

Authors:  Alessia Parascandolo; Mikko O Laukkanen
Journal:  Antioxid Redox Signal       Date:  2018-11-22       Impact factor: 8.401

8.  MCU Overexpression Rescues Inotropy and Reverses Heart Failure by Reducing SR Ca2+ Leak.

Authors:  Ting Liu; Ni Yang; Agnieszka Sidor; Brian O'Rourke
Journal:  Circ Res       Date:  2021-02-01       Impact factor: 17.367

Review 9.  Rho GTPase regulation of reactive oxygen species generation and signalling in platelet function and disease.

Authors:  Anh T P Ngo; Ivan Parra-Izquierdo; Joseph E Aslan; Owen J T McCarty
Journal:  Small GTPases       Date:  2021-04-12

Review 10.  Photocontrolled activation of small molecule cancer therapeutics.

Authors:  M Michael Dcona; Koushambi Mitra; Matthew C T Hartman
Journal:  RSC Med Chem       Date:  2020-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.